Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.65
Schlusskurs vom Vortag:
$2.65
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$114.24M
Einnahmen:
$51.13M
Nettoeinkommen (Verlust:
$-93.80M
KGV:
0.00
EPS:
-2.23
Netto-Cashflow:
$-129.10M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.66
Repare Therapeutics Inc Stock (RPTX) Company Profile
Firmenname
Repare Therapeutics Inc
Sektor
Branche
Telefon
(857) 412-7018
Adresse
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
0.00 | 114.24M | 51.13M | -93.80M | -129.10M | -2.23 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-09 | Hochstufung | Stifel | Hold → Buy |
| 2023-02-03 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-12 | Herabstufung | Stifel | Buy → Hold |
| 2022-03-17 | Fortgesetzt | Goldman | Buy |
| 2021-09-23 | Eingeleitet | Stifel | Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2020-10-28 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-14 | Eingeleitet | Cowen | Outperform |
| 2020-07-14 | Eingeleitet | Goldman | Neutral |
| 2020-07-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten
Gains Recap: Should I hold or sell Repare Therapeutics Inc nowMarket Growth Review & Daily Volume Surge Signals - baoquankhu1.vn
Dip Buying: Is Repare Therapeutics Inc forming a bullish divergence2026 Sector Review & Daily Momentum Trading Reports - baoquankhu1.vn
REPARE THERAPEUTICS PB Ratio: 0.99 — 37% Below Median - GuruFocus
Trend Recap: Should I set a stop loss on Repare Therapeutics Inc2026 Action & Daily Entry Point Trade Alerts - baoquankhu1.vn
Stock Market Recap: Should I hold or sell Repare Therapeutics Inc nowInsider Selling & Free High Return Stock Watch Alerts - baoquankhu1.vn
Aug Mood: Should I hold or sell Repare Therapeutics Inc now2026 Catalysts & Consistent Profit Trade Alerts - baoquankhu1.vn
Bearish Setup: How does Grid Dynamics Holdings Inc score in quality rankingsMarket Sentiment Review & Community Verified Watchlist Alerts - baoquankhu1.vn
Chipmakers Recap: Is Repare Therapeutics Inc stock heavily shorted2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn
Layoff Watch: Does Repare Therapeutics Inc have declining or rising EPSQuarterly Profit Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Repare Therapeutics announces shareholder meeting for acquisition approval - MSN
RPTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Repare Therapeutics Inc. stock benefit from infrastructure spendingCEO Change & Expert Curated Trade Ideas - mfd.ru
Is Repare Therapeutics Inc forming a bullish divergenceForecast Cut & Low Volatility Stock Recommendations - baoquankhu1.vn
Will Repare Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Spike Watch & Risk Controlled Swing Trade Alerts - mfd.ru
[15-12G] Repare Therapeutics Inc. SEC Filing - Stock Titan
How Repare Therapeutics Inc. stock reacts to oil prices2025 Price Targets & Verified Technical Trade Signals - mfd.ru
Is Repare Therapeutics Inc. stock heavily shortedMarket Risk Summary & AI Driven Price Forecasts - mfd.ru
Why Repare Therapeutics Inc. stock could outperform in 2025July 2025 Market Mood & Safe Capital Growth Tips - mfd.ru
Is Repare Therapeutics Inc. stock a smart buy before Fed meetingEarnings Beat & Community Shared Stock Ideas - mfd.ru
Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 - marketscreener.com
Gilead’s Growing Oncology Role Reshapes The Investment Case For GILD - Sahm
Published on: 2026-02-02 06:19:02 - baoquankhu1.vn
Shay Capital LLC's Strategic Acquisition of Repare Therapeutics Inc Shares - GuruFocus
Repare Therapeutics completes acquisition and goes private - The Globe and Mail
Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Up 125.3% in January - MarketBeat
Repare Announces Completion of Acquisition by XenoTherapeutics - citybiz
Repare Therapeutics Announced Transfer or Voluntary Withdrawal of Listing - TradingView
RPTX Stock Price, Quote & Chart | REPARE THERAPEUTICS INC (NASDAQ:RPTX) - ChartMill
Repare Shareholders Approve Acquisition by XenoTherapeutics - citybiz
Repare Shareholders approve acquisition by XenoTherapeutics - Medical Buyer
Repare Therapeutics (RPTX) Shareholders Approve Acquisition by X - GuruFocus
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc. - Investing News Network
Repare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics - TipRanks
99.76% of Repare voters back takeover by nonprofit XenoTherapeutics - Stock Titan
Bank Watch: Is Repare Therapeutics Inc stock heavily shorted2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Update - MarketBeat
Update Report: Is Repare Therapeutics Inc stock heavily shorted2025 Market Trends & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4%Here's Why - MarketBeat
Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% – Here’s Why - Defense World
Levels Update: Is Repare Therapeutics Inc. stock a top pick in earnings season2025 Sector Review & Daily Stock Trend Watchlist - Bộ Nội Vụ
Aug Opening: Will Repare Therapeutics Inc stock attract ESG investorsMarket Sentiment Summary & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Insider Trends: Why Repare Therapeutics Inc. stock is in analyst buy zonePortfolio Update Report & Capital Efficient Trading Techniques - Bộ Nội Vụ
Published on: 2026-01-13 02:16:07 - baoquankhu1.vn
What catalysts could drive Repare Therapeutics Inc. stock higherTrade Exit Summary & Smart Investment Allocation Tips - Улправда
Oklahoma City NewsThe OklahomanRepare Therapeutics Inc.Common Shares (Nasdaq:RPTX) Stock Quote - FinancialContent
Is Repare Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 Review & Risk Managed Trade Strategies - Улправда
Can Repare Therapeutics Inc. stock sustain free cash flow growthJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда
Will Repare Therapeutics Inc. stock benefit from commodity prices2025 Big Picture & Momentum Based Trading Signals - ulpravda.ru
Repare Therapeutics sells RP-3467 cancer program assets to Gilead for up to $30 million - MSN
Can Repare Therapeutics Inc. stock double in next 5 yearsVolatility Adjusted Trading & Learn to Trade with Real-Time Feedback - Улправда
Repare Therapeutics Inc.Common Shares (NQ: RPTX - FinancialContent
Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):